产品特点
Revised: December 2010
AN: 01369/2010
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Ampicillinvet 250mg Hard Capsules
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains:
Active Ingredient
mg per capsule
Ampicillin
250
_ _
(as ampicillin trihydrate)
Capsule Body
Erythrosine (E127)
0.952
Quinoline yellow (E104)
0.004
Patent blue V (E131)
0.002
Titanium dioxide (E171)
0.368
Capsule cap
Ferric oxide black (E172)
0.146
Titanium dioxide (E171)
0.488
Ink:
Black iron oxide (E172)
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Capsules, hard
Red and grey hard capsules with the logo ‘AMP/250’ in black ink
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
Page 1 of 6
Revised: December 2010
AN: 01369/2010
4.2 INDICATIONS FOR USE
Ampicillinvet is indicated in the treatment and control of diseases caused by or
associated with bacterial pathogens sensitive to ampicillin. These include the
following groups of pathogens:
Streptococcus spp, Pasturella haemolytica, P. multocida, Staphylococcus aureus
and other pathogenic staphylococci
When susceptible organisms are present, treatment with Ampicillinvet may be
effective in the following indications:
Alimentary tract infections
Respiratory infections
Urinary tract infections
4.3 CONTRAINDICATIONS
Not to be administered to animals known to be sensitive to penicillin.
Not to be administered to small herbivores.
Do not treat dogs of less than 10kg bodyweight.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5 SPECIAL PRECAUTIONS FOR USE, INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN BY THE
PERSON ADMINISTERING THE MEDICINAL PRODUCT TO THE ANIMALS
i. Specials precautions for use in animals
Whenever possible, the Ampicillinvet Capsules s
阅读完整的文件